Headache and malaria: A brief review

Acta Neurologica Taiwanica

Volumn 18, Issue 1, 2009, Pages 56-59

  Wiwanitkit, Viroj ^a  

^a NONE   (Thailand)

Author keywords

Headache; Malaria

Indexed keywords

ANTIMALARIAL AGENT; CORTICOSTEROID; CYTOKINE; INTERLEUKIN 1; MEFLOQUINE; QUININE; TUMOR NECROSIS FACTOR;

BRAIN MALARIA; CARDIOTOXICITY; CLINICAL FEATURE; CONCENTRATION LOSS; DISEASE ASSOCIATION; DRUG INDUCED HEADACHE; FATIGUE; GASTROINTESTINAL SYMPTOM; HEADACHE; HEARING IMPAIRMENT; HEART CONDUCTION; HUMAN; HYPOTENSION; MALARIA; MEMORY DISORDER; MOOD DISORDER; NAUSEA; NERVOUSNESS; NEUROLOGIC DISEASE; NEUROPATHOLOGY; PSYCHOSIS; REVIEW; SIDE EFFECT; SLEEP DISORDER; SWEATING; SYMPTOMATOLOGY; VASODILATATION;

ANTIMALARIALS; BRAIN; CYTOKINES; HEADACHE; HUMANS; MALARIA; MALARIA, CEREBRAL; SYNDROME;

EID: 63249124480     PISSN: 10196099     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Nájera JA. Malaria and activities of the World Health Organization. Bol Oficina Sanit Panam 1991;111:131-51.
2. McDevitt MA, Xie J, Gordenk V, et al. The anemia of malaria infection: role of inflammatory cytokines. Curr Hematol Rep 2004;3:97-106.
3. McGuire W, Knight JC, Hill AV, et al. Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles. J Infect Dis 1999; 179:287-90.
4. Suyaphun A, Wiwanitkit V, Suwansaksri J, et al. Malaria among hilltribe communities in northern Thailand: a review of clinical manifestations. Southeast Asian J Trop Med Public Health 2002;33 Suppl 3:14-5.
5. Benson J, Davis J. Malaria in the Australian refugee population. Aust Fam Physician 2007;36:639-41,656.
6. Faiz MA, Rahman MR, Hossain MA, et al. Cerebral malaria: a study of 104 cases. Bangladesh Med Res Counc Bull 1998;24:35-42.
7. Mishra SK, Mohanty S, Satpathy SK, et al. Cerebral malaria in adults: a description of 526 cases admitted to Ispat General Hospital in Rourkela, India. Ann Trop Med Parasitol 2007;101:187-93.
8. Clark IA, Jacobson LS. Do babesiosis and malaria share a common disease process? Ann Trop Med Parasitol 1998; 92:483-8.
9. John CC, Park GS, Sam-Agudu N, et al. Elevated serum levels of IL-1ra in children with Plasmodium falciparum malaria are associated with increased severity of disease. Cytokine 2008;41:204-8.
10. McGuire W, Hill AV, Greenwood BM, et al. Circulating ICAM-1 levels in falciparum malaria are high but unrelated to disease severity. Trans R Soc Trop Med Hyg 1996;90: 274-6.
11. Armah H, Dodoo AK, Wiredu EK, et al. High-level cerebellar expression of cytokines and adhesion molecules in fatal, paediatric, cerebral malaria. Ann Trop Med Parasitol 2005;99:629-47.
12. Armah H, Wired EK, Dodoo AK, et al. Cytokines and adhesion molecules expression in the brain in human cerebral malaria. Int J Environ Res Public Health 2005;2:123-31.
13. Gbadoé AD. Headache in malaria. Arch Pediatr 2000; 7:569-70.
14. Kabilan L, Bagga AK. Headache, a major symptom in Plasmodium vivax malaria; a clinical report. Indian J Med Sci 1996;50:370-1.
15. Jacqz-Aigrain E, Bennasr S, Desplanques L, et al. Severe poisoning risk linked to intravenous administration of quinine. Arch Pediatr 1994;1:14-9.
16. Hachfi-Soussi F, Coudert V, Biron R, et al. Acute quinine poisoning treated with high dose of diazepam. Arch Fr Pediatr 1993;50:485-8.
17. Bateman DN, Dyson EH. Quinine toxicity. Adverse Drug React Acute Poisoning Rev 1986;5:215-33.
18. Kitchener SJ, Nasveld PE, Gregory RM, et al. Mefloquine and doxycycline malaria prophylaxis in Australian soldiers in East Timor. Med J Aust 2005;182:168-71.
19. Croft AM, Herxheimer A. Adverse effects of the antimalaria drug, mefloquine: due to primary liver damage with secondary thyroid involvement? BMC Public Health 2002;2:6.
20. Kollaritsch H, Karbwang J, Wiedermann G, et al. Mefloquine concentration profiles during prophylactic dose regimens. Wien Klin Wochenschr 2000;112:441-7.
21. Bunnag D, Malikul S, Chittamas S, et al. Fansimef for prophylaxis of malaria: a double-blind randomized placebo controlled trial. Southeast Asian J Trop Med Public Health 1992;23:777-82.
22. Rendi-Wagner P, Noedl H, Wernsdorfer WH, et al. Unexpected frequency, duration and spectrum of adverse events after therapeutic dose of mefloquine in healthy adults. Acta Trop 2002;81:167-73.
23. Hsieh CF, Shih PY, Lin RT. Postmalaria neurologic syndrome: a case report. Kaohsiung J Med Sci 2006;22:630-5.
24. van der Wal G, Verhagen WI, Dofferhoff AS. Neurological complications following Plasmodium falciparum infection. Neth J Med 2005;63:180-3.
25. Falchook GS, Malone CM, Upton S, et al. Postmalaria neurological syndrome after treatment of Plasmodium falciparum malaria in the United States. Clin Infect Dis 2003; 37:e22-4.
26. Nguyen TH, Day NP, Ly VC, et al. Post-malaria neurological syndrome. Lancet 1996;348:917-21.